A SR-NET 3D-to-2D Architecture For Paraseptal Emphysema Segmentation

• Published in: 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019) Vol. 2019; pp. 303 - 306
• Main Authors: Bermejo-Pelaez, D., Okajima, Y., Washko, G. R., Ledesma-Carbayo, M. J., Estepar, R. San Jose
• Format: Conference Proceeding Journal Article
• Language: English
• Published: United States IEEE 01-04-2019
• Subjects: Computed tomography; Convolutional neural networks; Deep learning; Image segmentation; Lesions; Lung; Parasetal emphysema; Segmentation; Three-dimensional displays; Training; Two dimensional displays; Deep learning; Segmentation; Convolutional neural networks; Parasetal emphysema
• ISSN: 1945-7928; 1945-8452
• DOI: 10.1109/ISBI.2019.8759184

Paraseptal emphysema (PSE) is a relatively unexplored emphysema subtype that is usually asymptomatic, but recently associated with interstitial lung abnormalities which are related with clinical outcomes, including mortality. Previous local-based methods for emphysema subtype quantification do not properly characterize PSE. This is in part for their inability to properly capture the global aspect of the disease, as some the PSE lesions can involved large regions along the chest wall. It is our assumption, that path-based approaches are not well-suited to identify this subtype and segmentation is a better paradigm. In this work we propose and introduce the Slice-Recovery network (SR-Net) that leverages 3D contextual information for 2D segmentation of PSE lesions in CT images. For that purpose, a novel convolutional network architecture is presented, which follows an encoding-decoding path that processes a 3D volume to generate a 2D segmentation map. The dataset used for training and testing the method comprised 664 images, coming from 111 CT scans. The results demonstrate the benefit of the proposed approach which incorporate 3D context information to the network and the ability of the proposed method to identify and segment PSE lesions with different sizes even in the presence of other emphysema subtypes in an advanced stage.